Price
No data yet.
Social Signal Score
Analyst Ratings
2 analystsRevenue
$770.0K+487.79%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Michael Edell
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Employees
- 24
- Beta
- 0.24
- Country
- US
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- -22.47
Financials
Revenue
$770.0K+487.8%Net Income
$-1.83MEBITDA
$-1.80MFree Cash Flow
$-1.71MEPS (diluted)
$-0.35Shares Outstanding (diluted)
5.30M+20612.5%Operating Expenses
$2.43MCash & Debt
$5.08MReturn of Capital
$173.0KRevenue by Segment (annual)
$1.02MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.22M | $-6.38M | $-1.95 |
| 2024 | $1.86M | $-6.18M | $-8.86 |
| 2023 | $1.19M | $-7.71M | $-115.10 |
| 2022 | $1.02M | $-9.70M | $-1860.00 |
| 2021 | $576.0K | $-8.27M | $-1773.00 |
| 2020 | $258.0K | $-7.94M | $-6683.98 |
| 2019 | $143.0K | $-10.02M | $-18457.00 |
| 2018 | $297.0K | $-11.91M | $-30283.00 |
| 2017 | $52.0K | $-12.29M | $-53760.00 |
| 2016 | $318.0K | $-10.79M | $-82080.00 |
| 2015 | $241.0K | $-18.17M | $-86.40 |
| 2014 | $199.0K | $-7.20M | $-34.08 |
Valuation
SNEShas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100+0.00%Social Signal Score
Mentions (5)
- Newsprnewswire.com·13d ago·Neutral
SenesTech Expands Third-Party E-commerce Distribution with Grove Collaborative, Bringing Evolve® Rodent Birth Control™ Products to Sustainability-Focused Consumers SURPRISE, Ariz., Sept. 23, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that its Evolve® family of rodent birth control products will soon be available through Grove Collaborative's online marketplace.
View source ↗ - Newsprnewswire.com·18d ago·Neutral
SenesTech to Participate in the Lytham Partners Fall 2026 Investor Conference PHOENIX, Sept. 17, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference, taking place virtually on September 29-30, 2026.
View source ↗ - Newsprnewswire.com·36d ago·Negative
Swampscott Municipal Integrated Pest Management Program Achieves 43% Reduction in Rodent Activity with Evolve® Rat SURPRISE, Ariz., Aug. 31, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that a six-month deployment of Evolve® Rat as part of a comprehensive Integrated Pest Management program reduced measured rodent activity by 43% at a municipal facility in Swampscott, Massachusetts.
View source ↗ - Newsprnewswire.com·39d ago·Neutral
SenesTech Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) SURPRISE, Ariz., Aug. 27, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that its Board of Directors has granted an inducement equity award to John Karabees in connection with his appointment as Executive Vice President, Sales.
View source ↗ - Newsprnewswire.com·49d ago·Neutral
SenesTech to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026 SURPRISE, Ariz., Aug. 17, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in fertility control for managing animal pest populations, today announced that it will participate in a webcast presentation at the Lytham Partners 2026 Consumer & Technology Investor Summit, taking place virtually on Tuesday, August 18, 2026.
View source ↗
Earnings
Mon, Nov 9(in 5 weeks)
Consensus estimate $-0.33 per share
Typical surprise +6.1% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 5$-0.35 vs $-0.36beat
- Tue, May 12$-0.31 vs $-0.33beat
- Thu, Mar 12$-0.29 vs $-0.30beat
- Mon, Nov 10$-0.28 vs $-0.35beat
- Wed, Mar 12$-1.22 vs $-1.50beat
Estimates and results for SNES via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by SNES officers and directors.
- Bought
- $1.2m
- Sold
- $171
42 trades
2 trades
- Edell Michaelbought
- Edell Michaelbought
- Edell Michaelbought
- Edell Michaelbought
- Edell Michaelbought
- Glenbrook Capital Managementbought
- Glenbrook Capital Managementbought
- Glenbrook Capital Managementbought
56 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in SNES.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.